Assertio Holdings Inc logo

ASRT - Assertio Holdings Inc Share Price

$1.03 -0.1  -4.6%

Last Trade - 3:36pm

Sector
Healthcare
Size
Small Cap
Market Cap £70.0m
Enterprise Value £31.7m
Revenue £153.1m
Position in Universe 4216th / 6316
Bullish
Bearish
Unlock ASRT Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Assertio Holdings Inc revenues decreased 64% to $20.9M. Net income totaled $41.2M vs. loss of $14.3M. Revenues reflect Commercialization agreement, net decrease of 64% to $11.3M, Product sales, net decrease of 65% to $9.3M, Royalties and milestones decrease of 35% to $407K. Net Income reflects Amortization of intangible assets decrease of 69% to $7.8M (expense), IE on Capital Financing.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ASRT Revenue Unlock ASRT Revenue

Net Income

ASRT Net Income Unlock ASRT Revenue

Normalised EPS

ASRT Normalised EPS Unlock ASRT Revenue

PE Ratio Range

ASRT PE Ratio Range Unlock ASRT Revenue

Dividend Yield Range

ASRT Dividend Yield Range Unlock ASRT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ASRT EPS Forecasts Unlock ASRT Revenue
Profile Summary

Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX capsules, ZIPSOR Liquid filled capsules and ZORVOLEX capsules. The Company is also focused on developing and commercializing neurology, orphan and specialty medicines. Its pipeline products include Diclofenac Potassium, Long-acting Cosyntropin and Diclofenac potassium. Diclofenac Potassium is being developed for mild/moderate acute pain. Long-acting Cosyntropin is being developed for diagnosis of adrenal insufficiency. Diclofenac potassium is a liquid formulation being developed for acute migraine attacks.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
No. of Shareholders: 19
No. of Employees: 125
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 81,492,578
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ASRT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ASRT
Upcoming Events for ASRT
Frequently Asked Questions for Assertio Holdings Inc
What is the Assertio Holdings Inc share price?

As of 3:36pm, shares in Assertio Holdings Inc are trading at $1.03, giving the company a market capitalisation of £70.0m. This share price information is delayed by 15 minutes.

How has the Assertio Holdings Inc share price performed this year?

Shares in Assertio Holdings Inc are currently trading at $1.03 and the price has moved by -66.36% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Assertio Holdings Inc price has moved by -69.14% over the past year.

What are the analyst and broker recommendations for Assertio Holdings Inc?

Of the analysts with advisory recommendations for Assertio Holdings Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Assertio Holdings Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Assertio Holdings Inc next release its financial results?

Assertio Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Assertio Holdings Inc dividend yield?

Assertio Holdings Inc does not currently pay a dividend.

Does Assertio Holdings Inc pay a dividend?

Assertio Holdings Inc does not currently pay a dividend.

When does Assertio Holdings Inc next pay dividends?

Assertio Holdings Inc does not currently pay a dividend.

How do I buy Assertio Holdings Inc shares?

To buy shares in Assertio Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Assertio Holdings Inc?

Shares in Assertio Holdings Inc are currently trading at $1.03, giving the company a market capitalisation of £70.0m.

Where are Assertio Holdings Inc shares listed? Where are Assertio Holdings Inc shares listed?

Here are the trading details for Assertio Holdings Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ASRT
What kind of share is Assertio Holdings Inc?

Based on an overall assessment of its quality, value and momentum, Assertio Holdings Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Assertio Holdings Inc share price forecast 2020?

Shares in Assertio Holdings Inc are currently priced at $1.03. At that level they are trading at 25% discount to the analyst consensus target price of 0.00.

Analysts covering Assertio Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of 0.11 for the next financial year.

How can I tell whether the Assertio Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Assertio Holdings Inc. Over the past six months, the relative strength of its shares against the market has been 54.23%. At the current price of $1.03, shares in Assertio Holdings Inc are trading at 4.67% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Assertio Holdings Inc PE Ratio?

We were not able to find PE ratio data for Assertio Holdings Inc.

Who are the key directors of Assertio Holdings Inc?

We were unable to find the directors for Assertio Holdings Inc.

Who are the major shareholders of Assertio Holdings Inc?

Here are the top five shareholders of Assertio Holdings Inc based on the size of their shareholding:

CR Group Private Equity
Percentage owned: 14.07% (11.5m shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 7.68% (6.26m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 6.33% (5.16m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.18% (4.22m shares)
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund
Percentage owned: 4.81% (3.92m shares)
Similar to ASRT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.